Dynamic Contrast-Enhanced Magnetic Resonance Imaging Study for Biochemocal Failures after Radical Prostatectomy

Dynamic Contrast-Enhanced Magnetic Resonance Imaging Study for Biochemocal Failures after Radical Prostatectomy - DCE-MRI for BFRP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009823

Enrollment

Registered

2013-01-21

Start date

2012-07-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

To detect recurrence with 3-tesla dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and biopsy for prostate bed for patients with bichemical failure after radical prostatectomy. And to de

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with pathologically proven prostate cancer who underwent radical prostatectomy and present biochemical failure after PSA nadir.

Exclusion criteria

Exclusion criteria: Patients who are at risk for MRI study, for local biopsy of prostate bed, who cannot make their own decision, or patients who are considered inadequate by attendant physicians.

Design outcomes

Primary

Measure	Time frame
Validity of DCE-MRI for PSA failure	—

Countries

Japan

Contacts

Public ContactKenshiro Shiraishi

The University of Tokyo Hospital Department of Radiology

kshiraishi-tky@umin.ac.jp0338155411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026